Steven R. Pacelli - 23 Feb 2023 Form 4 Insider Report for DEXCOM INC (DXCM)

Role
EVP Managing Director Dexcom V
Signature
By: Jereme Sylvain For: Steven R. Pacelli
Issuer symbol
DXCM
Transactions as of
23 Feb 2023
Transactions value $
-$45,996
Form type
4
Filing time
23 Feb 2023, 17:34:34 UTC
Previous filing
02 Feb 2023
Next filing
10 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Sale -$46K -412 -0.3% $111.64 136K 23 Feb 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On September 15, 2022, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan.
F2 Included in this number are 45,820 unvested restricted stock units, 19,936 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 14,136 of which were granted on March 8, 2021 and shall vest through March 8, 2024, and 11,748 of which were granted on March 8, 2020 and shall vest through March 8, 2023.